Allie H. Grossmann

Medical Genetics

1950 Circle Of Hope Dr Ste N3105
Salt Lake City, UT 84112

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 43 publications

Novel Pattern of Nuclear Staining With ROS1 Immunohistochemistry: A Case Report.

Novel Pattern of Nuclear Staining With ROS1 Immunohistochemistry: A Case Report.

Journal: Case reports in pulmonology

Published: October 14, 2025

CIT tumor lines: A series of immunogenic murine cutaneous squamous cell carcinoma cell lines derived from chemical carcinogenesis.

CIT tumor lines: A series of immunogenic murine cutaneous squamous cell carcinoma cell lines derived from chemical carcinogenesis.

Journal: JID innovations : skin science from molecules to population health

Published: September 11, 2025

Rapid activation of ARF6 after RAF inhibition augments BRAFV600E and promotes therapy resistance.

Rapid activation of ARF6 after RAF inhibition augments BRAFV600E and promotes therapy resistance.

Journal: Research square

Published: September 05, 2025

Rapid activation of ARF6 after RAF inhibition augments BRAFV600E and promotes therapy resistance.

Rapid activation of ARF6 after RAF inhibition augments BRAFV600E and promotes therapy resistance.

Journal: Oncogene

Published: August 08, 2025

CIT tumor lines: A novel series of immunogenic cutaneous squamous cell carcinoma cell lines derived from chemical carcinogenesis.

CIT tumor lines: A novel series of immunogenic cutaneous squamous cell carcinoma cell lines derived from chemical carcinogenesis.

Journal: bioRxiv : the preprint server for biology

Published: April 28, 2025

Receptor tyrosine kinase inhibition leads to regression of acral melanoma by targeting the tumor microenvironment.

Receptor tyrosine kinase inhibition leads to regression of acral melanoma by targeting the tumor microenvironment.

Journal: Journal of experimental & clinical cancer research : CR

Published: July 16, 2024

SLC7A5 is required for cancer cell growth under arginine-limited conditions.

SLC7A5 is required for cancer cell growth under arginine-limited conditions.

Journal: Cell reports

Published: July 12, 2024

Receptor tyrosine kinase inhibition leads to regression of acral melanoma by targeting the tumor microenvironment.

Receptor tyrosine kinase inhibition leads to regression of acral melanoma by targeting the tumor microenvironment.

Journal: bioRxiv : the preprint server for biology

Published: July 01, 2024

Tumour-intrinsic endomembrane trafficking by ARF6 shapes an immunosuppressive microenvironment that drives melanomagenesis and response to checkpoint blockade therapy.

Tumour-intrinsic endomembrane trafficking by ARF6 shapes an immunosuppressive microenvironment that drives melanomagenesis and response to checkpoint blockade therapy.

Journal: Nature communications

Published: January 04, 2024

ARF6-dependent endocytic trafficking of the Interferon-γ receptor drives adaptive immune resistance in cancer.

ARF6-dependent endocytic trafficking of the Interferon-γ receptor drives adaptive immune resistance in cancer.

Journal: bioRxiv : the preprint server for biology

Published: October 24, 2023

Correction: Activation of NFAT by HGF and IGF-1 via ARF6 and its effector ASAP1 promotes uveal melanoma metastasis.

Correction: Activation of NFAT by HGF and IGF-1 via ARF6 and its effector ASAP1 promotes uveal melanoma metastasis.

Journal: Oncogene

Published: September 08, 2023

Feasibility of personalized circulating tumor DNA detection in stage II and III melanoma.

Feasibility of personalized circulating tumor DNA detection in stage II and III melanoma.

Journal: Melanoma research

Published: April 11, 2023

Showing 1-12 of 43

Last Updated: 09/26/2026